FiercePharma1h
FDA slams Indian drugmaker Unexo with warning letter for 'significant violations'
Unexo Life Sciences, an Indian drugmaker that manufactures a medicated patch for pain relief, has been hit with a ...
FiercePharma2h
AstraZeneca to go on defense for Andexxa as FDA questions bleeding reversal agent's safety ahead of adcomm
As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...
FiercePharma22h
With patent settlement, BeiGene defends blockbuster Brukinsa from MSN's generic threat until 2037
As BeiGene works to change its corporate identity and grow the reach of its cancer offerings around the globe, the company ...
FiercePharma23h
Neurology patient groups call out pharma for inadequate investment in treating disease
Neurology patient groups have chided the pharma industry for investing too little into treating disorders of the nervous ...
FiercePharma23h
Exact Sciences ramps up colon cancer outreach to Hispanic community with Carlos Ponce partnership
On the heels of the premiere of its first-ever Spanish-language Cologuard campaign, Exact Sciences is doubling down on its ...
FiercePharma20h
Endo expands clonazepam recall to cover more than a dozen additional batches
After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of ...